VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SABS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SABSSAB Biotherapeutics, Inc.
$3.03$283M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSABSQuarterly Balance Sheet

SAB Biotherapeutics, Inc. (SABS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

SAB Biotherapeutics, Inc. (SABS) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

SABS Balance Sheet

Quarterly statement

SABS Balance Sheet

SAB Biotherapeutics, Inc. (SABS) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets107.74M107.94M112.78M101.05M113.28M9.31M16.3M23.79M32.54M39.58M46.95M58.91M3.13M9.01M15.03M22.1M22.18M27.75M36.17M50.19M
Cash & Short-Term Investments104.05M102.63M107.39M96.59M110.88M5.71M12.85M20.76M30.4M37.33M44.06M56.57M2.43M7.77M13.06M15.05M8.33M16.62M22.41M33.21M
Cash Only14.44M8.27M20.52M10.5M29.42M3.69M5.64M8.9M9.17M17.24M14.03M56.57M2.43M7.77M13.06M15.05M8.33M16.62M22.41M33.21M
Short-Term Investments89.61M94.36M86.87M86.09M81.46M2.02M7.21M11.86M21.23M20.08M30.02M000000000
Accounts Receivable1.5M1.84M1.56M946.78K559.95K021.39K54.95K97.05K224.92K193.23K00364.12K763.12K5.56M12.94M9.61M11.79M8.01M
Days Sales Outstanding-------60.96-72.318.62--599.75489.39393.79289.03153.3275.4875.81
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets03.46M3.84M3.51M1.84M3.59M3.42M2.98M2.04M00000000006.34M
Total Non-Current Assets127.91M130.27M135.69M71.76M70.17M20.82M21.82M20.4M21.26M22.31M24.42M25.03M25.21M26.44M27.64M28.81M30.33M31.4M31.3M30.95M
Property, Plant & Equipment20.81M19.58M20.17M19.4M19.44M20.4M21.37M19.92M20.75M21.79M22.63M24.68M24.84M26M27.21M28.34M29.82M30.87M31.3M30.95M
Fixed Asset Turnover-------0.01x-0.01x0.04x0.01x0.05x0.00x0.02x0.07x0.12x0.20x0.38x0.37x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments101.29M105.35M110.24M46.89M50.61M000001.24M000000000
Other Non-Current Assets5.81M5.34M5.28M5.46M124.07K417.49K449.79K482.1K514.41K521.72K554.03K350.23K371.19K434K434K467.69K501.39K535.08K00
Total Assets235.64M238.21M248.47M172.81M183.45M30.13M38.12M44.2M53.8M61.89M71.37M83.94M28.34M35.44M42.67M50.9M52.51M59.15M67.47M81.14M
Asset Turnover-------0.00x-0.00x0.01x0.01x0.04x0.00x0.01x0.04x0.06x0.10x0.16x0.17x
Asset Growth %28.45%690.62%551.81%291.01%241%-51.32%-46.59%-47.35%89.85%74.63%67.25%64.9%-46.03%-40.09%-36.76%-37.26%2.69%9.12%-42.47%-
Total Current Liabilities14.8M11.71M9.85M10.68M10.79M10.68M9.65M7.98M8.82M7.55M8.3M10.81M9.21M11.01M13.67M14.99M17.1M16.14M18.26M26.46M
Accounts Payable2.42M3.85M3.54M3.15M2.95M2.62M2.52M1.69M1.3M1.17M1.24M945.93K1.08M1.4M1.44M3.68M5.48M4.94M4.98M4.46M
Days Payables Outstanding--400.02367.66335.16284.6724.77175.15117.43107.3550.1198.83116.09145.27249.77456.42527.1752.61-37.07
Short-Term Debt0641K0951.37K00138.55K275.85K524.74K615.82K835.47K1.05M541.64K784.88K444.48K772.66K1.38M1.33M1.33M1.8M
Deferred Revenue (Current)00000000114.7K114.7K377.83K1.32M1.63M2.89M2.94M0000100K
Other Current Liabilities00386.33K1.55M000001.01M1.28M4.49M4.43M4.22M923.16K8.1M6.32M6.06M8.85M8.7M
Current Ratio7.28x9.22x11.45x9.46x10.50x0.87x1.69x2.98x3.69x5.24x5.65x5.45x0.34x0.82x1.10x1.47x1.30x1.72x1.98x1.90x
Quick Ratio7.28x9.22x11.45x9.46x10.50x0.87x1.69x2.98x3.69x5.24x5.65x5.45x0.34x0.82x1.10x1.47x1.30x1.72x1.98x1.90x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities9.93M11.72M11.37M10.63M7.58M7.44M7.06M10.25M8.08M8.22M10.24M15.83M3.87M4.72M4.6M4.85M4.78M5.9M7.96M16.14M
Long-Term Debt04.49M00000000000541.64K541.64K541.64K0000
Capital Lease Obligations4.35M05.25M5M5.2M5.46M5.71M3.86M4M4.13M3.94M4.05M3.45M3.58M3.82M3.99M4.43M4.76M5.09M5.42M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities5.58M7.23M6.12M5.64M2.38M1.98M1.35M6.39M4.08M4.09M6.31M11.77M417.1K595.86K238.34K320.93K357.52K1.14M2.87M10.72M
Total Liabilities24.72M23.43M21.22M21.32M18.37M18.11M16.71M18.23M16.89M15.77M18.55M26.64M13.08M15.73M18.27M19.85M21.88M22.03M26.21M42.59M
Total Debt4.92M5.13M6.17M5.95M6.19M6.42M6.78M4.67M4.52M5.34M5.45M5.91M4.65M5.58M5.46M5.93M7.16M7.4M7.71M8.52M
Net Debt-9.52M-3.13M-14.35M-4.55M-23.24M2.73M1.14M-4.23M-4.65M-11.9M-8.58M-50.66M2.23M-2.2M-7.6M-9.12M-1.17M-9.22M-14.69M-24.69M
Debt / Equity0.02x0.02x0.03x0.04x0.04x0.53x0.32x0.18x0.12x0.12x0.10x0.10x0.30x0.28x0.22x0.19x0.23x0.20x0.19x0.22x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--361.76x-299.73x-264.68x1050.74x-156.19x-73.70x-159.77x-131.62x-77.78x-64.81x-292.49x-72.21x-90.36x-78.60x-88.50x-99.19x-91.85x15.97x-24.94x
Total Equity210.92M214.78M227.25M151.49M165.07M12.02M21.41M25.97M36.9M46.12M52.82M57.3M15.26M19.72M24.4M31.06M30.62M37.12M41.26M38.55M
Equity Growth %27.77%1687.46%961.54%483.35%347.32%-73.95%-59.47%-54.68%141.89%133.92%116.46%84.49%-50.18%-46.89%-40.85%-19.43%-12.7%-2.97%-62.28%-
Book Value per Share2.262.694.243.182.121.292.302.803.994.985.729.672.913.914.846.167.128.639.008.87
Total Shareholders' Equity210.92M214.78M227.25M151.49M165.07M12.02M21.41M25.97M36.9M46.12M52.82M57.3M15.26M19.72M24.4M31.06M30.62M37.12M41.26M38.55M
Common Stock9K8K7.58K4.77K4.76K9369369359299299299295.29K5.29K5.09K5.09K4.36K4.36K4.35K4.35K
Retained Earnings-174.56M-152.25M-129.76M-110.9M-94.03M-139.48M-129.37M-124.17M-112.77M-102.42M-95.09M-90.06M-67.21M-62.1M-55.22M-47.87M-40M-32.92M-28.14M-29.13M
Treasury Stock-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M-5.52M0
Accumulated OCI-2.3M-930K-222.76K186.51K71.22K-15.8K-111.59K-135.41K52.13K-31.35K-63.45K26.42K00000000
Minority Interest00000000000000000000